Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
HGFAC Biologics Sequence Review Report 2026: Hepatocyte growth factor activator serine protease Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
HGFAC Biologics Sequence Review Report 2026: Hepatocyte growth factor activator serine protease Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of HGFAC protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
FCER1G Biologics Sequence Review Report 2026: High affinity immunoglobulin epsilon receptor subunit gamma Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
FCER1G Biologics Sequence Review Report 2026: High affinity immunoglobulin epsilon receptor subunit gamma Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of FCER1G protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
EPS15L1 Biologics Sequence Review Report 2026: Epidermal growth factor receptor substrate 15-like 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
EPS15L1 Biologics Sequence Review Report 2026: Epidermal growth factor receptor substrate 15-like 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of EPS15L1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ADGRG7 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G7 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ADGRG7 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G7 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRG7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
EPS15 Biologics Sequence Review Report 2026: Epidermal growth factor receptor substrate 15 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
EPS15 Biologics Sequence Review Report 2026: Epidermal growth factor receptor substrate 15 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of EPS15 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
DNER Biologics Sequence Review Report 2026: Delta and Notch-like epidermal growth factor-related receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
DNER Biologics Sequence Review Report 2026: Delta and Notch-like epidermal growth factor-related receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of DNER protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ADGRL4 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L4 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ADGRL4 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRL4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ADGRF2P Biologics Sequence Review Report 2026: Putative adhesion G protein-coupled receptor F2P Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ADGRF2P Biologics Sequence Review Report 2026: Putative adhesion G protein-coupled receptor F2P Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRF2P protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ADGRG1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ADGRG1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRG1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ADGRE5 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor E5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ADGRE5 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor E5 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRE5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ADGRF4 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor F4 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ADGRF4 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor F4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRF4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ADGRE2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor E2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ADGRE2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor E2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRE2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →